Arthritis Drug Being Studied as Possible COVID-19 Treatment, Sent to Doctors

Doctors test hospital staff with flu-like symptoms for the CCP virus in tents set up to triage possible COVID-19 patients outside before they enter the main emergency department area at St. Barnabas hospital in the Bronx borough of New York City on March 24, 2020. Misha Friedman/Getty Images

A drug currently approved to treat arthritis and now being studied as a possible treatment for COVID-19, the disease caused by the new CCP virus from China, was sent to doctors in the United States, the company that manufactures the drug said.

The Epoch Times refers to the novel coronavirus as the CCP virus because the Chinese Communist Party’s coverup and mishandling allowed the virus to spread throughout China and create a global pandemic.